메뉴 건너뛰기




Volumn 88, Issue 1, 2014, Pages 3-15

New inhaler devices - The good, the bad and the ugly

Author keywords

Aerosols; Asthma; Chronic obstructive pulmonary disease; Inhalers; Nebulisers

Indexed keywords

ARTICLE; DRUG DELIVERY SYSTEM; DRY POWDER INHALER; HUMAN; INHALER; METERED DOSE INHALER; NEBULIZER; PATIENT COMPLIANCE; PRIORITY JOURNAL; INHALATIONAL DRUG ADMINISTRATION; TRENDS; AEROSOL; ASTHMA; BREATHING PATTERN; CHRONIC OBSTRUCTIVE LUNG DISEASE; HOME NEBULIZER; LUNG FUNCTION; MEDICAL NEBULIZER; OBSTRUCTIVE AIRWAY DISEASE; PARTICLE SIZE;

EID: 84903539170     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000363390     Document Type: Article
Times cited : (126)

References (67)
  • 1
    • 79958008114 scopus 로고    scopus 로고
    • What the pulmonary specialist should know about the new inhalation therapies
    • Laube BL, Janssens HM, de Jongh FHC, et al: What the pulmonary specialist should know about the new inhalation therapies. Eur Respir J 2011; 37: 1308-1331.
    • (2011) Eur Respir J , vol.37 , pp. 1308-1331
    • Laube, B.L.1    Janssens, H.M.2    De Jongh, F.H.C.3
  • 2
    • 13544253826 scopus 로고    scopus 로고
    • Device selection and outcomes of aerosol therapy: Evidence-based guidelines: American college of chest physicians/american college of asthma, allergy, and immunology
    • Dolovich MB, Ahrens Rc, Hess DR, et al: Device selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest 2005; 127: 335-371.
    • (2005) Chest , vol.127 , pp. 335-371
    • Dolovich, M.B.1    Rc, A.2    Hess, D.R.3
  • 3
    • 79952763932 scopus 로고    scopus 로고
    • Aerosol drug delivery: Developments in device design and clinical use
    • Dolovich MB, Dhand R: Aerosol drug delivery: developments in device design and clinical use. Lancet 2011: 377: 1032-1045.
    • (2011) Lancet , vol.377 , pp. 1032-1045
    • Dolovich, M.B.1    Dhand, R.2
  • 4
    • 84903551277 scopus 로고    scopus 로고
    • Global Initiative for Asthma: Global Strategy for Asthma Management and Prevention. updated December
    • Global Initiative for Asthma: Global Strategy for Asthma Management and Prevention. http://www.ginaasthma.com (updated December 2012).
    • (2012)
  • 5
    • 84903540904 scopus 로고    scopus 로고
    • Global Initiative for Chronic Obstructive Lung Disease: Global Strategy for Diagnosis, Management, and Prevention of COPD. update
    • Global Initiative for Chronic Obstructive Lung Disease: Global Strategy for Diagnosis, Management, and Prevention of COPD. http://www.goldcopd.org/ uploads/users/files/GOLD-Report-2011-Jan21.pdf (2011 update).
    • (2011)
  • 6
    • 84894506129 scopus 로고    scopus 로고
    • Improving inhaler technique, adherence to therapy and the precision of dosing: Major challenges for pulmonary drug delivery
    • Newman S: Improving inhaler technique, adherence to therapy and the precision of dosing: major challenges for pulmonary drug delivery. Expert Opin Drug Deliv 2014; 11: 365-378.
    • (2014) Expert Opin Drug Deliv , vol.11 , pp. 365-378
    • Newman, S.1
  • 7
    • 26944474854 scopus 로고    scopus 로고
    • Deposition of inhaled particles in the human respiratory tract and consequences for regional targeting in respiratory drug delivery
    • Heyder J: Deposition of inhaled particles in the human respiratory tract and consequences for regional targeting in respiratory drug delivery. Proc Am Thorac Soc 2004; 1: 315-320.
    • (2004) Proc Am Thorac Soc , vol.1 , pp. 315-320
    • Heyder, J.1
  • 8
    • 79957454222 scopus 로고    scopus 로고
    • Retail sales of inhalation devices in European countries: So much for a global policy
    • Lavorini F, Corrigan CJ, Barnes PJ, et al: Retail sales of inhalation devices in European countries: so much for a global policy. Respir Med 2011; 105: 1099-1113.
    • (2011) Respir Med , vol.105 , pp. 1099-1113
    • Lavorini, F.1    Corrigan, C.J.2    Barnes, P.J.3
  • 9
    • 79955499377 scopus 로고    scopus 로고
    • Cost-effectiveness of metered-dose inhalers for asthma exacerbations in the pediatric emergency department
    • Doan Q, Shefrin A, Johnson D: Cost-effectiveness of metered-dose inhalers for asthma exacerbations in the pediatric emergency department. Pediatrics 2011; 127: 1105-1111.
    • (2011) Pediatrics , vol.127 , pp. 1105-1111
    • Doan, Q.1    Shefrin, A.2    Johnson, D.3
  • 10
    • 34047146927 scopus 로고    scopus 로고
    • Withdrawal of albuterol inhalers containing chlorofluorocarbon propellants
    • Hendeles L, Colice GL, Meyer RJ: Withdrawal of albuterol inhalers containing chlorofluorocarbon propellants. N Engl J Med 2007; 356: 1344-1351.
    • (2007) N Engl J Med , vol.356 , pp. 1344-1351
    • Hendeles, L.1    Colice, G.L.2    Meyer, R.J.3
  • 11
    • 0032827577 scopus 로고    scopus 로고
    • Advances in metered dose inhaler technology with the development of a chlorofluorocarbon-free drug delivery system
    • Ross DL, Gabrio BJ: Advances in metered dose inhaler technology with the development of a chlorofluorocarbon-free drug delivery system. J Aerosol Med 1999; 12: 151-160.
    • (1999) J Aerosol Med , vol.12 , pp. 151-160
    • Ross, D.L.1    Gabrio, B.J.2
  • 12
    • 11144283302 scopus 로고    scopus 로고
    • Modulite: A means of designing the aerosols generated by pressurized metered dose inhalers
    • Ganderton D, Lewis D, Davies R, et al: Modulite: a means of designing the aerosols generated by pressurized metered dose inhalers. Respir Med 2002; 96(suppl D):S3-S8.
    • (2002) Respir Med , vol.96 , Issue.SUPPL. D
    • Ganderton, D.1    Lewis, D.2    Davies, R.3
  • 13
    • 33644621503 scopus 로고    scopus 로고
    • The CFC to HFA transition and its impact on pulmonary drug development
    • Leach CL: The CFC to HFA transition and its impact on pulmonary drug development. Respir Care 2005; 50: 1201-1208.
    • (2005) Respir Care , vol.50 , pp. 1201-1208
    • Leach, C.L.1
  • 15
    • 0032764740 scopus 로고    scopus 로고
    • A new method to evaluate plume characteristics of hydrofluoroalkane and chlorofluorocarbon metered dose inhalers
    • Gabrio BJ, Stein SW, Velasquez DJ: A new method to evaluate plume characteristics of hydrofluoroalkane and chlorofluorocarbon metered dose inhalers. Int J Pharm 1999; 186: 3-12.
    • (1999) Int J Pharm , vol.186 , pp. 3-12
    • Gabrio, B.J.1    Stein, S.W.2    Velasquez, D.J.3
  • 16
    • 33846999016 scopus 로고    scopus 로고
    • Advances in asthma and COPD management: Delivering CFC-free inhaled therapy using Modulite technology
    • Acerbi D, Brambilla G, Kottakis I: Advances in asthma and COPD management: delivering CFC-free inhaled therapy using Modulite technology. Pulm Pharmacol Ther 2007; 20: 290-303.
    • (2007) Pulm Pharmacol Ther , vol.20 , pp. 290-303
    • Acerbi, D.1    Brambilla, G.2    Kottakis, I.3
  • 17
    • 33747362898 scopus 로고    scopus 로고
    • Beclometasone dipropionate/formoterol: In an HFA-propelled pressurised metered-dose inhaler
    • Dhillon S, Keating GM: Beclometasone dipropionate/formoterol: in an HFA-propelled pressurised metered-dose inhaler. Drugs 2006; 66: 1475-1483.
    • (2006) Drugs , vol.66 , pp. 1475-1483
    • Dhillon, S.1    Keating, G.M.2
  • 18
    • 30444452988 scopus 로고    scopus 로고
    • Regional lung deposition and bronchodilator response as a function of beta2-agonist particle size
    • Usmani OS, Biddiscombe MF, Barnes PJ: Regional lung deposition and bronchodilator response as a function of beta2-agonist particle size. Am J Respir Crit Care Med 2005; 172: 1497-504.
    • (2005) Am J Respir Crit Care Med , vol.172 , pp. 1497-1504
    • Usmani, O.S.1    Biddiscombe, M.F.2    Barnes, P.J.3
  • 19
    • 84874342044 scopus 로고    scopus 로고
    • Prospective, open-label assessment of albuterol sulfate hydrofluoroalkane metered-dose inhaler with new integrated dose counter
    • Given J, Taveras H, Iverson H, Lepore M: Prospective, open-label assessment of albuterol sulfate hydrofluoroalkane metered-dose inhaler with new integrated dose counter. Allergy Asthma Proc 2013; 34: 42-51.
    • (2013) Allergy Asthma Proc , vol.34 , pp. 42-51
    • Given, J.1    Taveras, H.2    Iverson, H.3    Lepore, M.4
  • 21
    • 79957528899 scopus 로고    scopus 로고
    • Dose counter performance of mometasone furoate/formoterol inhalers in subjects with asthma or COPD
    • Weinstein C, Staudinger H, Scott I, Amar NJ, LaForce C: Dose counter performance of mometasone furoate/formoterol inhalers in subjects with asthma or COPD. Respir Med 2011; 105: 979-988.
    • (2011) Respir Med , vol.105 , pp. 979-988
    • Weinstein, C.1    Staudinger, H.2    Scott, I.3    Amar, N.J.4    Laforce, C.5
  • 22
    • 84880520454 scopus 로고    scopus 로고
    • Improving asthma management: The case for mandatory inclusion of dose counters on all rescue bronchodilators
    • Conner JB, Buck PO: Improving asthma management: the case for mandatory inclusion of dose counters on all rescue bronchodilators. J Asthma 2013; 50: 658-563.
    • (2013) J Asthma , vol.50 , pp. 658-563
    • Conner, J.B.1    Buck, P.O.2
  • 23
    • 33746347407 scopus 로고    scopus 로고
    • The need to improve inhalation technique in Europe: A report from the Aerosol Drug Management Improvement Team
    • Crompton GK, Barnes PJ, Broeder M, et al: The need to improve inhalation technique in Europe: a report from the Aerosol Drug Management Improvement Team. Respir Med 2006; 100: 1479-1494.
    • (2006) Respir Med , vol.100 , pp. 1479-1494
    • Crompton, G.K.1    Barnes, P.J.2    Broeder, M.3
  • 24
    • 0025951893 scopus 로고
    • Improvement of drug delivery with a breath actuated pressurised aerosol for patients with poor inhaler technique
    • Newman SP, Weisz A, Talaee N, Clarke S: Improvement of drug delivery with a breath actuated pressurised aerosol for patients with poor inhaler technique. Thorax 1991; 46: 712-716.
    • (1991) Thorax , vol.46 , pp. 712-716
    • Newman, S.P.1    Weisz, A.2    Talaee, N.3    Clarke, S.4
  • 25
    • 29844448453 scopus 로고    scopus 로고
    • Influence of particle size and patient dosing technique on lung deposition of HFAbeclomethasone from a metered dose inhaler
    • Leach CL, Davidson PJ, Hasselquist BE, Boudreau RJ: Influence of particle size and patient dosing technique on lung deposition of HFAbeclomethasone from a metered dose inhaler. J Aerosol Med 2005; 18: 379-385.
    • (2005) J Aerosol Med , vol.18 , pp. 379-385
    • Leach, C.L.1    Davidson, P.J.2    Hasselquist, B.E.3    Boudreau, R.J.4
  • 26
    • 0032970171 scopus 로고    scopus 로고
    • Handling and acceptability of the Easi-Breathe device compared with a conventional metered dose inhaler by patients and practice nurses
    • Price DB, Pearce L, Powell SR, Shirley J, Sayers MK: Handling and acceptability of the Easi-Breathe device compared with a conventional metered dose inhaler by patients and practice nurses. Int J Clin Pract 1999; 53: 31-36.
    • (1999) Int J Clin Pract , vol.53 , pp. 31-36
    • Price, D.B.1    Pearce, L.2    Powell, S.R.3    Shirley, J.4    Sayers, M.K.5
  • 27
    • 0027978050 scopus 로고
    • Reduction in patient timing errors using a breath-activated metered dose inhaler
    • Hampson NB, Mueller MP: Reduction in patient timing errors using a breath-activated metered dose inhaler. Chest 1994; 106: 462-465.
    • (1994) Chest , vol.106 , pp. 462-465
    • Hampson, N.B.1    Mueller, M.P.2
  • 28
    • 0034129205 scopus 로고    scopus 로고
    • Inappropriate inhaler use: Assessment of use and patient preference of seven inhalation devices
    • Lenny J, Innes J, Crompton GK: Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devices. Respir Med 2000; 94: 496-500.
    • (2000) Respir Med , vol.94 , pp. 496-500
    • Lenny, J.1    Innes, J.2    Crompton, G.K.3
  • 29
    • 84908235237 scopus 로고    scopus 로고
    • Technological and practical challenges of dry powder inhalers and formulations
    • DOI: 10.1016/j.addr.2014.04.004
    • Hoppentocht M, Hagedoorn P, Frijlink HW, de Boer AH: Technological and practical challenges of dry powder inhalers and formulations. Adv Drug Deliv Rev 2014 DOI: 10.1016/j.addr.2014.04.004.
    • (2014) Adv Drug Deliv Rev
    • Hoppentocht, M.1    Hagedoorn, P.2    Frijlink, H.W.3    De Boer, A.H.4
  • 30
    • 84862644228 scopus 로고    scopus 로고
    • Clarifying the dilemmas about inhalation techniques for dry powder inhalers: Integrating science with clinical practice
    • Azouz W, Chrystyn H: Clarifying the dilemmas about inhalation techniques for dry powder inhalers: integrating science with clinical practice. Prim Care Respir J 2012; 21: 208-213.
    • (2012) Prim Care Respir J , vol.21 , pp. 208-213
    • Azouz, W.1    Chrystyn, H.2
  • 31
    • 79961039597 scopus 로고    scopus 로고
    • Development of an inhaled dry-powder formulation of tobramycin using PulmoSphere TM technology
    • Geller DE, Weers J, Heuerding S: Development of an inhaled dry-powder formulation of tobramycin using PulmoSphere TM technology. J Aerosol Med Pulm Drug Deliv 2011; 24: 175-182.
    • (2011) J Aerosol Med Pulm Drug Deliv , vol.24 , pp. 175-182
    • Geller, D.E.1    Weers, J.2    Heuerding, S.3
  • 32
    • 0036586884 scopus 로고    scopus 로고
    • Evolution of dry powder inhaler design, formulation, and performance
    • Newman SP, Busse WW: Evolution of dry powder inhaler design, formulation, and performance. Respir Med 2002; 96: 293-304.
    • (2002) Respir Med , vol.96 , pp. 293-304
    • Newman, S.P.1    Busse, W.W.2
  • 33
    • 47049128164 scopus 로고    scopus 로고
    • Dry powder inhalers (DPIs)-A review of device reliability and innovation
    • Islam N, Gladki E: Dry powder inhalers (DPIs)-A review of device reliability and innovation. Int J Pharm 2008; 360: 1-11.
    • (2008) Int J Pharm , vol.360 , pp. 1-11
    • Islam, N.1    Gladki, E.2
  • 34
    • 33644644745 scopus 로고    scopus 로고
    • Dry powder inhalers: An overview
    • Atkins PJ: Dry powder inhalers: an overview. Respir Care 2005; 50: 1304-1312.
    • (2005) Respir Care , vol.50 , pp. 1304-1312
    • Atkins, P.J.1
  • 36
  • 37
    • 84889041619 scopus 로고    scopus 로고
    • Qualitative assessment of attributes and ease of use of the ELLIPTA TM dry powder inhaler for delivery of maintenance therapy for asthma and COPD
    • Svedsater H, Dale P, Garrill K, Walker R, Woepse MW: Qualitative assessment of attributes and ease of use of the ELLIPTA TM dry powder inhaler for delivery of maintenance therapy for asthma and COPD. BMC Pulm Med 2013; 13: 72.
    • (2013) BMC Pulm Med , vol.13 , pp. 72
    • Svedsater, H.1    Dale, P.2    Garrill, K.3    Walker, R.4    Woepse, M.W.5
  • 38
    • 84857262977 scopus 로고    scopus 로고
    • The Genuair inhaler: A novel, multidose dry powder inhaler
    • Chrystyn H, Niederlaender C: The Genuair inhaler: a novel, multidose dry powder inhaler. Int J Clin Pract 2012; 66: 309-317.
    • (2012) Int J Clin Pract , vol.66 , pp. 309-317
    • Chrystyn, H.1    Niederlaender, C.2
  • 39
    • 70349932082 scopus 로고    scopus 로고
    • Lung deposition of aclidinium bromide from Genuair, a multidose dry powder inhaler
    • Newman SP, Sutton DJ, Segarra R, Lamarca R, de Miquel G: Lung deposition of aclidinium bromide from Genuair, a multidose dry powder inhaler. Respiration 2009; 78: 322-328.
    • (2009) Respiration , vol.78 , pp. 322-328
    • Newman, S.P.1    Sutton, D.J.2    Segarra, R.3    Lamarca, R.4    De Miquel, G.5
  • 40
    • 70350704823 scopus 로고    scopus 로고
    • Peak inspiratory flow through the Genuair inhaler in patients with moderate or severe COPD
    • Magnussen H, Watz H, Zimmermann I, et al: Peak inspiratory flow through the Genuair inhaler in patients with moderate or severe COPD. Respir Med 2009; 103: 1832-1837.
    • (2009) Respir Med , vol.103 , pp. 1832-1837
    • Magnussen, H.1    Watz, H.2    Zimmermann, I.3
  • 41
    • 84859735921 scopus 로고    scopus 로고
    • Developing an efficient and reliable dry powder inhaler for pulmonary drug delivery-A review for multidisciplinary researchers
    • Islam N, Cleary MJ: Developing an efficient and reliable dry powder inhaler for pulmonary drug delivery-A review for multidisciplinary researchers. Med Eng Phys 2012; 34: 409-427.
    • (2012) Med Eng Phys , vol.34 , pp. 409-427
    • Islam, N.1    Cleary, M.J.2
  • 42
    • 0030916624 scopus 로고    scopus 로고
    • The science of nebulised drug delivery
    • O'Callaghan C, Barry PW: The science of nebulised drug delivery. Thorax 1997; 52(suppl 2):S31-S44.
    • (1997) Thorax , vol.52 , Issue.SUPPL. 2
    • O'Callaghan, C.1    Barry, P.W.2
  • 43
    • 0033944036 scopus 로고    scopus 로고
    • Nebulizers: Principles and performance
    • Hess DR: Nebulizers: principles and performance. Respir Care 2000: 45: 609-622.
    • (2000) Respir Care , vol.45 , pp. 609-622
    • Hess, D.R.1
  • 44
    • 0034895786 scopus 로고    scopus 로고
    • European Respiratory Society Guidelines on the use of nebulizers
    • Boe J, Dennis JH, O'Driscoll BR, et al: European Respiratory Society Guidelines on the use of nebulizers. Eur Respir J 2001; 18: 228-242.
    • (2001) Eur Respir J , vol.18 , pp. 228-242
    • Boe, J.1    Dennis, J.H.2    O'Driscoll, B.R.3
  • 45
    • 0029763316 scopus 로고    scopus 로고
    • Medication nebulizer performance Effects of diluent volume, nebulizer flow, and nebulizer brand
    • Hess DR, Fisher D, Williams P, Pooler S, Kacmarek RM: Medication nebulizer performance. Effects of diluent volume, nebulizer flow, and nebulizer brand. Chest 1996; 110: 498-505.
    • (1996) Chest , vol.110 , pp. 498-505
    • Hess, D.R.1    Fisher, D.2    Williams, P.3    Pooler, S.4    Kacmarek, R.M.5
  • 46
    • 77953948906 scopus 로고    scopus 로고
    • Omron NE U22: Comparison between vibrating mesh and jet nebulizer
    • Skaria S, Smaldone GC: Omron NE U22: comparison between vibrating mesh and jet nebulizer. J Aerosol Med Pulm Drug Deliv 2010; 23: 173-180.
    • (2010) J Aerosol Med Pulm Drug Deliv , vol.23 , pp. 173-180
    • Skaria, S.1    Smaldone, G.C.2
  • 47
    • 0036885621 scopus 로고    scopus 로고
    • Nebulisers that use a vibrating mesh or plate with multiple apertures to generate aerosol
    • Dhand R: Nebulisers that use a vibrating mesh or plate with multiple apertures to generate aerosol. Respir Care 2002; 47: 1406-1416.
    • (2002) Respir Care , vol.47 , pp. 1406-1416
    • Dhand, R.1
  • 48
    • 79958238207 scopus 로고    scopus 로고
    • A comparison of amount and speed of deposition between the PARI LC STAR ® jet nebulizer and an investigational eFlow ® nebulizer
    • Coates AL, Green M, Leung K, et al: A comparison of amount and speed of deposition between the PARI LC STAR ® jet nebulizer and an investigational eFlow ® nebulizer. J Aerosol Med Pulm Drug Deliv 2011; 24: 157-163.
    • (2011) J Aerosol Med Pulm Drug Deliv , vol.24 , pp. 157-163
    • Coates, A.L.1    Green, M.2    Leung, K.3
  • 49
    • 0031425587 scopus 로고    scopus 로고
    • Adaptive aerosol delivery: The principles
    • Nikander K: Adaptive aerosol delivery: the principles. Eur Respir Rev 1999; 7: 385-387.
    • (1999) Eur Respir Rev , vol.7 , pp. 385-387
    • Nikander, K.1
  • 50
    • 0031425588 scopus 로고    scopus 로고
    • Adaptive aerosol delivery in practice
    • Denyer J: Adaptive aerosol delivery in practice. Eur Respir Rev 1997; 7: 388-389.
    • (1997) Eur Respir Rev , vol.7 , pp. 388-389
    • Denyer, J.1
  • 51
    • 33947508961 scopus 로고    scopus 로고
    • Delivery of iloprost inhalation solution with the halolite, prodose, and i-neb adaptive aerosol delivery systems: An in vitro study
    • Van Dyke RE, Nikander K: Delivery of iloprost inhalation solution with the HaloLite, Prodose, and I-neb adaptive aerosol delivery systems: an in vitro study. Respir Care 2007; 52: 184-190.
    • (2007) Respir Care , vol.52 , pp. 184-190
    • Van Dyke, R.E.1    Nikander, K.2
  • 52
    • 82255167120 scopus 로고    scopus 로고
    • Pediatric aerosol therapy: New devices and new drugs
    • Rubin BK: Pediatric aerosol therapy: new devices and new drugs. Respir Care 2011; 56: 1411-1421.
    • (2011) Respir Care , vol.56 , pp. 1411-1421
    • Rubin, B.K.1
  • 53
    • 69249120315 scopus 로고    scopus 로고
    • Lung deposition of inhaled alpha1-proteinase inhibitor in cystic fibrosis and alpha1-antitrypsin deficiency
    • Brand P, Schulte M, Wencker M, et al: Lung deposition of inhaled alpha1-proteinase inhibitor in cystic fibrosis and alpha1-antitrypsin deficiency. Eur Respir J 2009; 34: 354-360.
    • (2009) Eur Respir J , vol.34 , pp. 354-360
    • Brand, P.1    Schulte, M.2    Wencker, M.3
  • 54
    • 0042026773 scopus 로고    scopus 로고
    • Peripheral deposition of alpha-1 protease inhibitor using commercial inhalation devices
    • Brand P, Beckmann H, Maas Enriquez M, et al: Peripheral deposition of alpha-1 protease inhibitor using commercial inhalation devices. Eur Respir J 2003; 22: 262-267.
    • (2003) Eur Respir J , vol.22 , pp. 262-267
    • Brand, P.1    Beckmann, H.2    Maas Enriquez, M.3
  • 58
    • 4444364706 scopus 로고    scopus 로고
    • A review of the development of Respimat soft mist inhaler
    • Dalby R, Spallek M, Voshaar T: A review of the development of Respimat soft mist inhaler. Int J Pharm 2004; 283: 1-9.
    • (2004) Int J Pharm , vol.283 , pp. 1-9
    • Dalby, R.1    Spallek, M.2    Voshaar, T.3
  • 59
    • 4344717797 scopus 로고    scopus 로고
    • A review of ipratropium bromide/fenoterol hydrobromide (Berodual) delivered via Respimat soft mist inhaler in patients with asthma and chronic obstructive pulmonary disease
    • Kassner F, Hodder R, Bateman ED: A review of ipratropium bromide/fenoterol hydrobromide (Berodual) delivered via Respimat soft mist inhaler in patients with asthma and chronic obstructive pulmonary disease. Drugs 2004; 64: 1671-1682.
    • (2004) Drugs , vol.64 , pp. 1671-1682
    • Kassner, F.1    Hodder, R.2    Bateman, E.D.3
  • 60
    • 40049096205 scopus 로고    scopus 로고
    • Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD
    • Lavorini F, Magnan A, Dubus JC, et al: Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD. Respir Med 2008; 102: 593-604.
    • (2008) Respir Med , vol.102 , pp. 593-604
    • Lavorini, F.1    Magnan, A.2    Dubus, J.C.3
  • 61
    • 77956792671 scopus 로고    scopus 로고
    • The chicago breathe project: A regional approach to improving education on asthma inhalers for resident physicians and minority patients
    • Press VG, Pincavage AT, Pappalardo AA: The Chicago Breathe Project: a regional approach to improving education on asthma inhalers for resident physicians and minority patients. J Natl Med Assoc 2010; 102: 548-555.
    • (2010) J Natl Med Assoc , vol.102 , pp. 548-555
    • Press, V.G.1    Pincavage, A.T.2    Pappalardo, A.A.3
  • 62
    • 0036178365 scopus 로고    scopus 로고
    • Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability
    • Giraud V, Roche N: Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability. Eur Respir J 2002; 19: 246-251.
    • (2002) Eur Respir J , vol.19 , pp. 246-251
    • Giraud, V.1    Roche, N.2
  • 63
    • 79955484156 scopus 로고    scopus 로고
    • Gruppo educazionale associazione italiana pneumologi ospedalieri inhaler mishandling remains common in real life and is associated with reduced disease control
    • Melani AS, Bonavia M, Cilenti V, Cinti C, Lodi M, Martucci P, Serra M, Scichilone N, Sestini P, Aliani M, Neri M: Gruppo Educazionale Associazione Italiana Pneumologi Ospedalieri. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med 2011; 105: 930-938.
    • (2011) Respir Med , vol.105 , pp. 930-938
    • Melani, A.S.1    Bonavia, M.2    Cilenti, V.3    Cinti, C.4    Lodi, M.5    Martucci, P.6    Serra, M.7    Scichilone, N.8    Sestini, P.9    Aliani, M.10    Neri, M.11
  • 64
    • 84888639007 scopus 로고    scopus 로고
    • Asthma patients' inability to use a pressurised metered-dose inhaler (pMDI) correctly correlates with poor asthma control as defined by the Global Initiative for Asthma (GINA) strategy: A retrospective analysis
    • Levy ML, Hardwell A, McKnight E, Holmes J: Asthma patients? inability to use a pressurised metered-dose inhaler (pMDI) correctly correlates with poor asthma control as defined by the Global Initiative for Asthma (GINA) strategy: a retrospective analysis. Prim Care Respir J 2013; 22: 406-411.
    • (2013) Prim Care Respir J , vol.22 , pp. 406-411
    • Levy, M.L.1    Hardwell, A.2    Mc Knight, E.3    Holmes, J.4
  • 65
    • 79551647479 scopus 로고    scopus 로고
    • ADMIT Working Group the ADMIT series-issues in inhalation therapy (6) Training tools for inhalation devices
    • Lavorini F, Levy ML, Corrigan C, Crompton G; ADMIT Working Group: The ADMIT series-issues in inhalation therapy. 6) Training tools for inhalation devices. Prim Care Respir J 2010; 19: 335-341.
    • (2010) Prim Care Respir J , vol.19 , pp. 335-341
    • Lavorini, F.1    Levy, M.L.2    Corrigan, C.3    Crompton, G.4
  • 66
    • 84871385237 scopus 로고    scopus 로고
    • Inhaler competence in asthma: Common errors, barriers to use and recommended solutions
    • Price D, Bosnic-Anticevich S, Briggs A, et al: Inhaler competence in asthma: common errors, barriers to use and recommended solutions. Respir Med 2013; 107: 37-46.
    • (2013) Respir Med , vol.107 , pp. 37-46
    • Price, D.1    Bosnic-Anticevich, S.2    Briggs, A.3
  • 67
    • 29744453224 scopus 로고    scopus 로고
    • Problems with inhaler use: A call for improved clinician and patient education
    • Fink JB, Rubin BK: Problems with inhaler use: a call for improved clinician and patient education. Respir Care 2005;50: 1360-1374.
    • (2005) Respir Care , vol.50 , pp. 1360-1374
    • Fink, J.B.1    Rubin, B.K.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.